Focal segmental glomerulosclerosis 2
MONDO:0011390Any focal segmental glomerulosclerosis in which the cause of the disease is a mutation in the TRPC6 gene.
Also known as: FSGS2, TRPC6 focal segmental glomerulosclerosis, focal segmental glomerulosclerosis 2, focal segmental glomerulosclerosis caused by mutation in TRPC6, focal segmental glomerulosclerosis type 2, glomerulosclerosis, focal segmental, 2
2 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New pill aims to slow kidney damage in FSGS patients
Disease control Recruiting nowThis study tests an oral medication called BI 764198 for people with a kidney condition called focal segmental glomerulosclerosis (FSGS). About 286 adults and teens will take either the study drug or a placebo daily for up to 2 years, while continuing their usual FSGS treatments.…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a diabetes drug protect kidneys in children with genetic disease?
Disease control Recruiting nowThis study tests whether adding dapagliflozin (a diabetes drug) to standard care reduces protein leakage in the urine of children with hereditary kidney diseases. About 44 children will receive either dapagliflozin plus standard care or standard care alone for 12 weeks, then swit…
Phase: PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC